- Are Soluble ST2 Levels in the Picogram or Nanogram Range in Serum of Healthy Subjects/Disease Patients?
-
Saluja R
- KMID: 1796931
- J Korean Med Sci.
- 2014 Jan;29(1):153-154.
- doi: 10.3346/jkms.2014.29.1.153
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Novel inflammatory biomarkers in acute coronary syndrome
-
Sim DS, Ahn Y
- KMID: 1501768
- Korean J Intern Med.
- 2013 Mar;28(2):156-158.
- doi: 10.3904/kjim.2013.28.2.156
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
-
Guzel S, Serin O, Guzel EC, Buyuk B, Yilmaz G, Guvenen G
- KMID: 1501771
- Korean J Intern Med.
- 2013 Mar;28(2):165-173.
- doi: 10.3904/kjim.2013.28.2.165
BACKGROUND/AIMS: Acute coronary syndrome (ACS) is characterized by increased inflammatory processes and endothelial activation. We investigated the association between ACS and inflammatory mediators and matrix-degrading enzymes. METHODS: We prospectively enrolled 55... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
-
Kim DJ, Baek SY, Park MK, Park KS, Lee JH, Park SH, Kim HY, Kwok SK
- KMID: 1793018
- J Korean Med Sci.
- 2013 Aug;28(8):1145-1153.
- doi: 10.3346/jkms.2013.28.8.1145
Interleukin (IL)-33 is an important mediator of innate immunity. Behcet's disease (BD) is an autoinflammatory disorder characterized by hyperactivity of the innate immune response. We measured serum levels of IL-33... -
- CITED
-
- Close
- SHARE
-
- Close
